| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 7.071 | 4.988 | 5.046 | 8.804 | 19.917 | 7.071 | 4.569 | 2.149 | 1.941 | 1.930 |
| Total Income - EUR | 7.071 | 4.991 | 5.046 | 8.804 | 19.917 | 7.071 | 4.569 | 2.149 | 1.941 | 1.930 |
| Total Expenses - EUR | 3.440 | 3.058 | 3.671 | 5.275 | 5.453 | 7.412 | 3.536 | 3.196 | 2.413 | 2.972 |
| Gross Profit/Loss - EUR | 3.631 | 1.932 | 1.375 | 3.528 | 14.464 | -340 | 1.033 | -1.046 | -473 | -1.042 |
| Net Profit/Loss - EUR | 3.419 | 1.783 | 1.223 | 3.264 | 13.867 | -553 | 898 | -1.110 | -566 | -1.042 |
| Employees | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Epimed Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | 7.334 | 8.723 | 10.001 | 12.885 | 22.142 | 21.216 | 21.440 | 14.634 | 11.742 | 10.388 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 0 | 0 | 1 | 0 | 3.170 | 3.169 | 3.660 | 3.507 | 3.916 | 4.186 |
| Cash | 7.334 | 8.723 | 10.000 | 12.885 | 18.972 | 18.047 | 17.780 | 11.127 | 7.826 | 6.202 |
| Shareholders Funds | 6.906 | 8.619 | 9.696 | 12.782 | 21.965 | 20.996 | 21.428 | 14.302 | 11.495 | 10.388 |
| Social Capital | 112 | 111 | 109 | 107 | 105 | 103 | 101 | 101 | 101 | 101 |
| Debts | 427 | 104 | 305 | 103 | 177 | 220 | 12 | 332 | 247 | 0 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "7499 - 7499" | |||||||||
| CAEN Financial Year |
7490
|
|||||||||
Comments - Epimed Srl